Exploring Case Studies & Supporting Preclinical Data Behind Targeting PD-L1, KLK3 & B7-H3 With Radiopharmaceuticals
- Demonstrating strong tumor uptake and imaging performance in Trop-2–positive cancers
- Highlighting opportunities to use Trop-2 expression for patient selection and treatment planning
- Establishing Trop-2 as a promising candidate for integrated diagnostic and therapeutic strategies